Lexicon Pharmaceuticals (LXRX)
Lexicon Pharmaceuticals News
LEXICON PHARMACEUTICALS, INC./DE Financials
about 20 days agoNew Star Analyst Rankings for Lexicon Pharmaceuticals, Inc.
about 26 days agoLexicon Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript
Seeking Alpha about 27 days agoLexicon Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript
Lexicon receives diabetes treatment funding
about 27 days agoLEXICON PHARMACEUTICALS, INC./DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme
about 27 days agoLexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
Benzinga about 27 days agoLexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
PR Newswire about 27 days agoTHE WOODLANDS, Texas, May 3, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, today updated ...
Wednesday's Bio Pharma Drug Approval And Catalyst Watch List
about 28 days agoLEXICON PHARMACEUTICALS, INC./DE Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articl
about 33 days agoLexicon to Provide First Quarter 2012 Financial Results
PR Newswire about 35 days agoTHE WOODLANDS, Texas, April 25, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (LXRX), announced today that it will release its first quarter 2012 financial results on Thursday, May 3, 2012 ...
Lexicon Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference
PR Newswire about 64 days agoTHE WOODLANDS, Texas, March 27, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX - News), announced today that Arthur T. Sands, M.D., Ph.D. , Lexicon's president and chief executive officer, will ...
Orphan Drug Status for Lexicon Drug
about 68 days agoOrphan Drug Status for Lexicon Drug - Analyst Blog
Zacks about 68 days agoLexicon Pharmaceuticals, Inc. announced that its candidate LX1032 has been granted orphan drug status by the FDA
Lexicon's drug telotristat gets FDA incentives
about 70 days agoYou may also be interested in these LXRX related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| LXRX | 1.61 | +0.01 | +0.62% | 773.70M |
| LXP | 8.30 | -0.09 | -1.07% | 1.290B |
| LSTR | 54.12 | +0.51 | +0.95% | 2.528B |
| LSI | 6.85 | -0.05 | -0.72% | 3.882B |
| LSG | 0.8744 | -0.02 | -1.75% | 358.71M |
| LSCC | 4.55 | +0.03 | +0.66% | 538.81M |
| LSBK | 9.23 | -0.77 | -7.70% | 54.83M |
| LOOP | 19.17 | +0.00 | +0.00% | 675.55M |
| LOOK | 0.80 | +0.02 | +2.58% | 13.83M |
| LONG | 13.96 | -0.02 | -0.14% | 471.85M |
